CORD-19:775b90287b44353bee979abb0970a4666022f86d / 81736-81825 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/775b90287b44353bee979abb0970a4666022f86d","sourcedb":"CORD-19","sourceid":"775b90287b44353bee979abb0970a4666022f86d","text":"The patient was placed on a monthly trial of Omalizumab 300 mg SQ for a total of 3 doses.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T84468","span":{"begin":0,"end":89},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T84468","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T319","span":{"begin":0,"end":89},"obj":"Sentence"}],"attributes":[{"subj":"T319","pred":"source","obj":"CORD-19_Custom_license_subset"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ecb293","default":true},{"id":"CORD-19_Custom_license_subset","color":"#9893ec"}]}]}}